Go to content
Careers
News & Insights
Contact
Search
Strategy
Toggle submenu
The Acuitas Advantage
Our Partnerships
Our Capabilities
Science
Toggle submenu
Our LNP Technology
Our Clinical Applications
Company
Toggle submenu
About Us
Our Team
Our Community Impact
Home
News
Article
September 4, 2025
Acuitas Therapeutics and collaborators demonstrate strong protection against
P. vivax
malaria with mRNA-LNP vaccine